Limited impact of 2 g/day Omega-3 fatty acid ethyl esters (Omacor®) on plasma lipids and inflammatory markers in patients awaiting carotid endarterectomy

Marine Drugs

Volumn 11, Issue 9, 2013, Pages 3569-3581

  Yusof, Hayati M ^a,b   Cawood, Abbie L ^a   Ding, Ren ^a   Williams, Jennifer A ^a   Napper, Frances L ^a   Shearman, Clifford P ^a   Grimble, Robert F ^a   Payne, Simon P K ^c   Calder, Philip C ^d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITI MALAYSIA TERENGGANU   (Malaysia)

^c QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Adhesion molecule; Cardiovascular disease; Cytokine; Fish oil; Omega 3

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CD40 LIGAND; CHOLESTEROL; CXCL9 CHEMOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; OLIVE OIL; OMEGA 3 ACID ETHYL ESTER; ORAL ANTIDIABETIC AGENT; PLACEBO; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CAROTID ARTERY DISEASES; CHOLESTEROL; DOCOSAHEXAENOIC ACIDS; DRUG COMBINATIONS; E-SELECTIN; EICOSAPENTAENOIC ACID; ENDARTERECTOMY, CAROTID; ESTERS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; LIPIDS; LIPOPROTEINS, LDL; MALE; MATRIX METALLOPROTEINASE 2; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84885063358     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11093569     Document Type: Article

References (32)

1. He, K.; Song, Y.; Daviglus, M.L.; Liu, K.; van Horn, L.; Dyer, A.R.; Greenland, P. Accumulated evidence on fish consumption and coronary heart disease mortality: A meta-analysis of cohort studies. Circulation 2004, 109, 2705-2711.
2. He, K.; Song, Y.; Daviglus, M.L.; Liu, K.; van Horn, L.; Dyer, A.R.; Goldbourt, U.; Greenland, P. Fish consumption and incidence of stroke: A meta-analysis of cohort studies. Stroke 2004, 35, 1538-1542.
3. Calder, P.C. n-3 Fatty acids and cardiovascular disease: Evidence explained and mechanisms explored. Clin. Sci. 2004, 107, 1-11.
4. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. American Heart Association Nutrition Committee. Circulation 2002, 106, 2747-2757.
5. Albert, C.M.; Campos, H.; Stampfer, M.J.; Ridker, P.M.; Manson, J.A.; Willett, W.C.; Ma, J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Eng. J. Med. 2002, 346, 1113-1118.
6. Hu, F.B.; Bronner, L.; Willett, W.C.; Stampfer, M.J.; Rexrode, K.M.; Albert, C.M.; Hunter, D.; Manson, J.E. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J. Am. Med. Assoc. 2002, 287, 1815-1821.
7. Morris, M.C.; Sacks, F.; Rosner, B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993, 88, 523-533.
8. Geleijnse, J.M.; Giltay, E.J.; Grobbee, D.E.; Donders, A.R.T.; Kok, F.J. Blood pressure response to fish oil supplementation: Meta-regression analysis of randomized trials. J. Hypertens. 2002, 20, 1493-1499.
9. Harris, W.S. n-3 Fatty acids and serum lipoproteins: Human studies. Am. J. Clin. Nutr. 1997, 65, 1645S-1654S.
10. Roche, H.M. Unsaturated fatty acids. Proc. Nutr. Soc. 1999, 58, 397-401.
11. Calder, P.C. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S-1519S.
12. Calder, P.C. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol. Nutr. Food. Res. 2012, 56, 1073-1080.
13. Scientific Advisory Committee on Nutrition/Committee on Toxicity. Advice on Fish Consumption: Benefits and Risks; The Stationary Office: Norwich, UK, 2004.
14. Abe, Y.; El Masri, B.; Kimball, K.T.; Pownall, H.; Reilly, C.F.; Osmundsen, K.; Smith, C.W.; Ballantyne, C.M. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 723-731.
15. Johansen, O.; Seljeflot, I.; Hostmark, A.T.; Arnesen, H. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1681-1686.
16. Davidson, M.H.; Stein, E.A.; Bays, H.E.; Maki, K.C.; Doyle, R.T.; Shalwitz, R.A.; Ballantyne, C.M.; Ginsberg, H.N.; Combination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study. Clin. Ther. 2007, 29, 1354-1367.
17. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999, 354, 447-455.
18. Marchioli, R.; Barzi, F.; Bomba, E.; Chieffo, C.; di Gregorio, D.; di Mascio, R.; Franzosi, M.G.; Geraci, E.; Levantesi, G.; Maggioni, A.P.; et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105, 1897-1903.
19. Cawood, A.L.; Ding, R.; Napper, F.L.; Young, R.H.; Williams, J.A.; Ward, M.J.; Gudmundsen, O.; Vige, R.; Payne, S.P.; Ye, S.; et al. Eicosapentanoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212, 252-259.
20. British Nutrition Foundation. Unsaturated Fatty Acids: Report of the British Nutrition Foundation Task Force; Blackwell Science: Oxford, UK, 1992.
21. Mayer, K.; Merfels, M.; Muhly-Reinholz, M.; Gokorsch, S.; Rosseau, S.; Lohmeyer, J.; Schwarzer, N.; Krüll, M.; Suttorp, N.; Grimminger, F.; et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: Role of endothelial PAF generation. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H811-H818.
22. Mori, T.A.; Burke, V.; Puddey, I.B.; Watts, G.F.; O'Neal, D.N.; Best, J.D.; Beilin, L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71, 1085-1094.
23. Durrington, P.N.; Bhatnagar, D.; Mackness, M.I.; Morgan, J.; Julier, K.; Khan, M.A.; France, M. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001, 85, 544-548.
24. Harris, W.S.; Sands, S.A.; Windsor, S.L.; Ali, H.A.; Stevens, T.L.; Magalski, A.; Porter, C.B.; Borkon, A.M. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110, 1645-1649.
25. Hjerkinn, E.M.; Seljeflot, I.; Ellingse, I.; Berstad, P.; Hjermann, I.; Sandvik, L.; Arnesen, H. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am. J. Clin. Nutr. 2005, 81, 583-589.
26. Eschen, O.; Christensen, J.H.; de Caterina, R.; Schmidt, E.B. Soluble adhesion molecules in healthy subjects: A dose-response study using n-3 fatty acids. Nutr. Metab. Cardiovasc. Dis. 2004, 14, 180-185.
27. Miles, E.A.; Thies, F.; Wallace, F.A.; Powell, J.R.; Hirst, T.L.; Newsholme, E.A.; Calder, P.C. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin. Sci. 2001, 100, 91-100.
28. Thies, F.; Nebe-von-Caron, G.; Powell, J.R.; Yaqoob, P.; Newsholme, E.A.; Calder, P.C. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 year. Am. J. Clin. Nutr. 2001, 73, 539-548.
29. Balk, E.M.; Lichtenstein, A.H.; Chung, M.; Kupelnick, B.; Chew, P.; Lau, J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006, 189, 19-30.
30. Carrero, J.J.; Fonolla, J.; Marti, J.L.; Jimenez, J.; Boza, J.J.; Lopez-Huertas, E. Intake of fish oil, oleic acid, folic acid, and vitamins B6 and E for one year decreases plasma C-reactive protein, and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J. Nutr. 2007, 137, 384-390.
31. Lee, K.W.; Blann, A.D.; Lip, G.Y. Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thromb. Res. 2006, 118, 305-312.
32. Aarsetøy, H.; Brügger-Andersen, T.; Hetland, Ø.; Grundt, H.; Nilsen, D.W. Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction. Thromb. Haemost. 2006, 95, 329-336.